Senate's New FDA User Fee Bill Adds Funds For Rare Diseases
Senators introduced revised legislation Tuesday to reauthorize user fee programs at the U.S. Food and Drug Administration, adding provisions to extend government grants for drugs used in rare diseases and calling...To view the full article, register now.
Already a subscriber? Click here to view full article